1. Zunt JR. Health care-associated meningitis and ventriculitis in adults: Clinical features and diagnosis. Ed:Tunkel AR. www.uptodate.com (Last accessed: Mart 2024)
2. Palabıyıkoglu I, Tekeli E, Cokca F et al. Nosocomial meningitis in a university hospital between 1993 and 2002. J Hosp Infect 2006; 62:94.
3. Tunkel RA, Hasbun R, Bhimraj A, et al. IDSA 2017 Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clinical Infectious Diseases, Volume 64, Issue 6, 15
March 2017, pages e34–e65.
4. Bardak Ozcem S, Sipahi OR. Approach to Hospital-Acquired and Methicillin-Resistant Staphylococcus aureus Meningitis. Mediterr J Infect Microb Antimicrob. 2013; 2:1.
5. Rogers T, Sok K, Erickson T, et al. Impact of Antibiotic Therapy in the Microbiological Yield of Healthcare-Associated Ventriculitis and Meningitis. Infect Dis 2019; 6:ofz050.
6. Sipahi OR, Zeka A, Tasbakan M. Pooled Analysis of 899 nosocomial meningitis episodes from Turkey. Turkish Journal of Medical Sciences. 2016; 1508-102.
7. Van de Beek D, Cabellos C, Dzupova O et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline: diagnosis and treatment of acute bacterial meningitis, Cli-
nical Microbiology and Infection 2016. p. 1-26.
8. Fulkerson DH, Sivaganesan A, Hill JD, et al. Progression of cerebrospinal fluid cell count and differential over a treatment course of shunt infection. J Neurosurg Pediatr 2011; 8:613.
9. Bardak-Ozcem S, Sipahi OR. An updated approach to healthcare-associated meningitis.
Expert Rev Anti Infect Ther. 2014 Mar;12(3):333-42.
10. Srihawan C, Castelblanco RL, Salazar L, et al. Clinical Characteristics and Predictors of Adverse Outcome in Adult and Pediatric Patients With Healthcare-Associated Ventriculitis and Me-
ningitis. Infect Dis 2016; 3:ofw077.
11. Torres S, Perdiz LB, Medeiros EA. Incidence of surgical site infection after craniotomy: comparison between three months and twelve months of epidemiological surveillance. Braz J Infect Dis
2018; 22:433.
12. Lozier AP, Sciacca RR, Romagnoli MF, et al. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery 2008; 62 Suppl 2:688.
13. Walti LN, Conen A, Coward J, et al. Characteristics of infections associated with external ventricular drains of cerebrospinal fluid. J Infect 2013; 66:424.
14. Van de Beek D, Cabellos C, Dzupova O et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guideline: diagnosis and treatment of acute bacterial meningitis,
Clinical Microbiology and Infection 2016. p. 1-26.
15. Ferreira NP, Otta GM, do Amaral LL, et al. Imaging aspects of pyogenic infections of the central nervous system. Top Magn Reson Imaging 2005; 16:145.
16. CDC/NHSN Surveillance Definitions for Specific Types of Infections https://www.cdc.gov/nhsn/pdfs/pscmanual/17pscnosinfdef_current.pdf (Accessed on August 10, 2022).
17. Sipahi OR, Akyol D, Ormen B, et al. Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis:
results of the multicenter Ephesus study. BMC Infect Dis. 2023; 23: 639.
18. Tunkel AR, Bhimraj A. Cerebrospinal fluid shunt and drain infections. Ed: Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 9.
ed. Philadelphia. 2020:1272-1280.
19. Zunt JR. Healthcare-associated meningitis and ventriculitis in adults: Treatment and prognosis. Ed:Tunkel AR. www.uptodate.com (Last accessed: March 2024)
20. Hasbun R. Update and advances in community acquired bacterial meningitis Curr Opin Infect Dis 2019; 32:233.
21. Li C, Zhou P, Liu Y, et al. Treatment of Ventriculitis and Meningitis After Neurosurgery Caused by Carbapenem-Resistant Enterobacteriaceae (CRE): A Challenging Topic. Infect Drug Re-
sist. 2023; 16: 3807–3818.
22. Sipahi OR, Mermer S, Demirdal T, et al. Tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii meningitis: Results of the Ege study. Clin Neurol Neurosurg. 2018
Sep:172:31-38.
23. Sipahi OR, Bardak S, Turhan T, et al. Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: a series of 17 cases. Scand J Infect Dis. 2011
Oct;43(10):757-64.
24. Sipahi OR, Bardak-Ozcem S, Turhan T, et al. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus meningitis. Surg Infect (Larchmt). 2013
Aug;14(4):357-62.
25. Arda B, Yamazhan T, Sipahi OR, et al. Meningitis due to methicillin-resistant Staphylococcus aureus (MRSA): review of 10 cases. Int J Antimicrob Agents. 2005 May;25(5):414-8.
26. Hasbun R. Treatment of bacterial meningitis caused by specific pathogens in adults. Ed:Tunkel AR. www.uptodate.com (Last accessed: June 2024)
27. Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, Whitley RJ. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004 Nov 1;39(9):1267-
84.
28. Ceylan B, Arslan F, Sipahi OR, et al. Variables determining mortality in patients with Acinetobacter baumannii meningitis/ventriculitis treated with intrathecal colistin. Clin Neurol Neuro-
surg. 2017 Feb:153:43-49.
29. Sanlıdağ Işbilen G, Akyol D, Yurtseven T et al. Intrathecal Tigecycline in the Treatment of Hospital-Acquired Meningitis: A Review of Four Cases. Surg Infect (Larchmt). 2024 Jul 26. doi:
10.1089/sur.2024.063.